Elevated hormone flags liver problems in mice with methylmalonic acidemia

Study findings can immediately be applied to human patients with the disease

11-Dec-2018 - Researchers have discovered that a hormone, fibroblast growth factor 21 (FGF21), is extremely elevated in mice with liver disease that mimics the same condition in patients with methylmalonic acidemia (MMA), a serious genomic disorder. Based on this finding, medical teams treating patients with ...

Abbott to Collaborate with Astellas in CMV Vaccine Trial

10-Sep-2012 - Abbott announced that it has signed an agreement to collaborate with Astellas Pharma Global Development in a Phase 3 clinical trial for ASP0113 (TransVax™), an investigational vaccine licensed from Vical Incorporated for preventing cytomegalovirus (CMV) reactivation in transplant patients.Under ...

High-Tech Gründerfonds invests in Humedics, a spin-off from Freie Universität Berlin and the Charité university hospital

26-Mar-2010 - Humedics markets a method for instantaneous measurement of liver function at the patient’s bedside. Known as the LiMAx Test, which was developed at the Charité University Hospital in Berlin by Dr Martin Stockmann and refined into a measurement system together with Prof. Karsten Heyne of Freie ...

Johns Hopkins University School of Medicine Presentation Highlights SELDI Technology for Proteomic Analysis in Kidney Transplant

Ciphergen's ProteinChip® System enables discovery of multiple biomarkers and predictive assay for kidney transplant rejection

25-Jun-2004 - Fremont, CA. Ciphergen Biosystems, Inc. (Nasdaq:CIPH) announced today the recent report of a promising study in kidney transplantation enabled by Ciphergen's SELDI ProteinChip® System. The findings were enabled by the use of proteomic pattern discovery and recognition methodologies pioneered by ...